Professor
Vanderbilt University School of Medicine
Nashville, Tennessee, United States
Friday, May 3, 2024
4:45 PM – 5:05 PM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Saturday, May 4, 2024
8:00 AM – 9:30 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Saturday, May 4, 2024
8:00 AM – 8:05 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Closing Remarks with APS President, Michael DeBaun
Saturday, May 4, 2024
9:25 AM – 9:30 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Saturday, May 4, 2024
11:00 AM – 12:30 PM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
APS President's Address - Academic Activism: Choosing the Right Time and the Right Place
Saturday, May 4, 2024
11:00 AM – 11:15 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Closing Remarks by APS President, Michael DeBaun
Saturday, May 4, 2024
12:28 PM – 12:30 PM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Improving Access to Quality Healthcare for Children and Adolescents in Custody
Sunday, May 5, 2024
8:00 AM – 9:30 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)
Sunday, May 5, 2024
8:00 AM – 8:05 AM ET
Disclosure(s): Forma Pharmaceutical (Terminated, December 31, 2022) (Products/Services: Consultant); Global Blood Therapeutics (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Advisory Committee)